Compare FMC Corp (FMC) vs ProShares Ultra QQQ ETF (QLD) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

QLD, the ProShares Ultra QQQ ETF, is currently trading at $88.73, down 3.69% on the day, reflecting a bearish technical signal. The leveraged ETF, which aims for 2x the daily return of the Nasdaq-100, lacks traditional fundamental ratios like P/E or P/S as it is a fund. Recent news highlights its long-term compounding power and ongoing discussions about its role in tactical portfolios and retirement strategies, though comparisons with higher-leverage alternatives like TQQQ note its relatively lower historical maximum drawdown.

The outlook for QLD is directly tied to the performance of the tech-heavy Nasdaq-100. While offering amplified daily returns, it carries significant risks from market volatility and compounding effects over longer periods. The primary opportunity is tactical participation in strong tech rallies, but the risk of severe drawdowns during downturns necessitates a cautious, short-term trading approach rather than a long-term buy-and-hold strategy.